3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow CVD: new trials by email Literature Review of CVD trials Research Report on CVD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting atorvastatin - CVD | Phase 4 | Completed | Jinling Hospital, China | 100 | 2011-01-01 | 2015-09-02 |
| Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting Argatroban, non-argatroban treated group - CVD | Phase 4 | Completed | Jinling Hospital, China | 114 | 2010-08-01 | 2015-11-23 |
| Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting Argatroban, non-argatroban treated group - CVD | Phase 4 | Completed | Xinfeng Liu | 114 | 2010-04-01 | 2015-10-23 |
Bites and Stings (1)
Chemically-Induced Disorders (1) · Poisoning (1) · Wounds and Injuries (1)
argatroban (2) · Aspirin (1) · Atorvastatin (1) · Clopidogrel (1) · Heparin (1)
Jinling Hospital, China (2) · Xinfeng Liu (1)
China (3)
Xinfeng Liu, MD (3)